GGrantIndex
← Leaderboards

Keck Graduate Inst Of Applied Life Scis

Claremont, CA

Compare ↔
$21,027,956
Total funding
27
Grants

Funding over time

peak $2.5M · FY2005–24
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$21,027,956 · 27

By mechanism

R01$16,774,431 · 12
R21$2,739,384 · 8
K25$565,640 · 1
K01$491,184 · 1
R03$392,022 · 4
R37$65,295 · 1

Investigators at Keck Graduate Inst Of Applied Life Scis

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Rachita Sumbria$4,336,9475 gr2Kiana Aran$2,446,5802 gr3Jeniffer Bertha Hernandez$767,8931 gr4Travis S. Schlappi$142,4251 gr

All-Time

Most funded here, all years

1Yao Liang Tang$6,672,2014 gr2Rachita Sumbria$4,336,9475 gr3Kiana Aran$2,446,5802 gr4James Michael Cregg$1,037,6774 gr5Karl Voelkerding$1,012,2932 gr6James D Sterling$806,7301 gr7Jeniffer Bertha Hernandez$767,8931 gr8Masa Narita$502,6401 gr

Largest grants

Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen$1,851,627
R01 · FY2021 · AI
Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen$1,219,945
R01 · FY2023 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$1,007,150
R01 · FY2010 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$846,903
R01 · FY2011 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$841,972
R01 · FY2012 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$803,134
R01 · FY2013 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$607,711
R01 · FY2014 · AI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$606,729
R01 · FY2008 · AI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$573,692
R01 · FY2009 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$555,804
R01 · FY2015 · AI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$547,185
R01 · FY2010 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$541,354
R01 · FY2016 · AI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$539,248
R01 · FY2011 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$538,394
R01 · FY2017 · AI
Modulation of the liver-brain axis by alcohol and its impact on Alzheimers disease pathology$427,374
R01 · FY2023 · AG
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease$409,227
R01 · FY2023 · HL
The impact of obesity-induced hepatic amyloid beta dysregulation on Alzheimer’s disease pathology$405,849
R21 · FY2024 · AG
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease$405,375
R01 · FY2022 · HL
Modulation of the liver-brain axis by alcohol and its impact on Alzheimers disease pathology$390,918
R01 · FY2021 · AG
A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease$390,183
R01 · FY2019 · AG